XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
2.540
-0.130 (-4.87%)
At close: May 8, 2026, 4:00 PM EDT
2.612
+0.072 (2.83%)
After-hours: May 8, 2026, 7:24 PM EDT
XTL Biopharmaceuticals Employees
XTL Biopharmaceuticals had 10 employees as of December 31, 2024. The number of employees increased by 3 or 42.86% compared to the previous year.
Employees
10
Change
3
Growth
42.86%
Revenue / Employee
$96,800
Profits / Employee
-$630,800
Market Cap
6.85M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 10 | 3 | 42.86% | 10 | 0 |
| Dec 31, 2016 | 7 | 1 | 16.67% | 2 | 5 |
| Dec 31, 2015 | 6 | 1 | 20.00% | 3 | 3 |
| Dec 31, 2014 | 5 | - | - | 3 | 2 |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 52 |
| BioAtla | 41 |
| PMGC Holdings | 34 |
| Bolt Biotherapeutics | 23 |
| Genprex | 13 |
| NuCana | 12 |
| Can-Fite BioPharma | 5 |
| Creative Medical Technology Holdings | 4 |
XTLB News
- 9 days ago - 3 Penny Stocks to Watch Now, 4/30/26 - TipRanks
- 10 days ago - XTL Biopharmaceuticals to acquire Psyga Bio - TheFly
- 10 days ago - XTL Biopharmaceuticals to Acquire Psyga Bio, Establishing a Leading Psychedelic Biotechnology Platform with Advanced Clinical Pipeline, Licensed GMP Manufacturing and Proprietary Psilocybin Technologies - GlobeNewsWire
- 6 weeks ago - XTL Biopharmaceuticals trading halted, news pending - TheFly
- 7 weeks ago - XTL Biopharmaceuticals (XTLB) Adjusts ADS to Ordinary Share Ratio - GuruFocus
- 7 weeks ago - XTL Biopharmaceuticals announces ADS ratio change - TheFly
- 7 weeks ago - XTL Biopharmaceuticals Announces ADS Ratio Change - GlobeNewsWire
- 2 months ago - Beyond Air announces termination of NeuroNOS agreement with XTL - TheFly